Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, and pretomanid (BPaL)-based regimens for pulmonary tuberculosis resistant to rifampicin. Study: Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial. Image Credit: fizkes/Shutterstock.com Background The TB-PRACTECAL […]
» Read more